Projects per year
Fingerprint
Dive into the research topics where Roxana S Dronca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Establishment of an Inclusive Cancer Care Research Equity (iCCaRE) for Black Men Consortium
9/30/22 → …
Project: Research project
-
Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma
8/17/15 → 7/31/16
Project: Research project
-
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Wen, T., Barham, W., Li, Y., Zhang, H., Gicobi, J. K., Hirdler, J. B., Liu, X., Ham, H., Peterson Martinez, K. E., Lucien, F., Lavoie, R. R., Li, H., Correia, C., Monie, D. D., An, Z., Harrington, S. M., Wu, X., Guo, R., Dronca, R. S., Mansfield, A. S., & 9 others, Feb 2022, In: Cancer Immunology Research. 10, 2, p. 162-181 20 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Robert, C., Hwu, W. J., Hamid, O., Ribas, A., Weber, J. S., Daud, A. I., Hodi, F. S., Wolchok, J. D., Mitchell, T. C., Hersey, P., Dronca, R., Joseph, R. W., Boutros, C., Min, L., Long, G. V., Schachter, J., Puzanov, I., Dummer, R., Lin, J., Ibrahim, N., & 3 others, Feb 2021, In: European Journal of Cancer. 144, p. 182-191 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance
Orme, J. J., Jazieh, K. A., Xie, T., Harrington, S., Liu, X., Ball, M., Madden, B., Charlesworth, M. C., Azam, T. U., Lucien, F., Wootla, B., Li, Y., Villasboas, J. C., Mansfield, A. S., Dronca, R. S. & Dong, H., Jan 1 2020, In: OncoImmunology. 9, 1, 1744980.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations
DeLeon, T. T., Almquist, D. R., Kipp, B. R., Langlais, B. T., Mangold, A., Winters, J. L., Kosiorek, H. E., Joseph, R. W., Dronca, R. S., Block, M. S., McWilliams, R. R., Kottschade, L. A., Rumilla, K. M., Voss, J. S., Seetharam, M., Sekulic, A., Markovic, S. N. & Bryce, A. H., 2020, In: PloS one. 15, 3, e0230306.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
Vera Aguilera, J., Paludo, J., Mcwilliams, R. R., Zhang, H., Li, Y., Kumar, A. B., Failing, J., Kottschade, L. A., Block, M. S., Markovic, S. N., Dong, H., Dronca, R. S. & Yan, Y., Aug 1 2020, In: Melanoma research. 30, 4, p. 364-375 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations